Skip to content
10-Q

Quarterly Report

THERABIOGEN, INC.

0001393905-12-000394

← back to feed
Filed
Jul 23, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 31, 2012 71.39M sh
Operating Cash Flow Q1 2012 · May 31, 2012 −$45.06K
Operating Cash Flow Q1 2012 · May 31, 2011 −$169.35K
Cash And Equivalents Q1 2012 · May 31, 2012 $166
Cash And Equivalents Q1 2012 · Feb 29, 2012 $290
Cash And Equivalents Q1 2012 · May 31, 2011 $39
Stockholders Equity Q1 2012 · May 31, 2012 −$157.96K
Stockholders Equity Q1 2012 · Feb 29, 2012 $35.72K
Current Liabilities Q1 2012 · May 31, 2012 $2.82M
Current Liabilities Q1 2012 · Feb 29, 2012 $2.69M
Total Liabilities Q1 2012 · May 31, 2012 $2.83M
Total Liabilities Q1 2012 · Feb 29, 2012 $2.69M
Current Assets Q1 2012 · May 31, 2012 $469.15K
Current Assets Q1 2012 · Feb 29, 2012 $470K
Total Assets Q1 2012 · May 31, 2012 $2.67M
Total Assets Q1 2012 · Feb 29, 2012 $2.73M
Sga Expense Q1 2012 · May 31, 2012 $300.28K
Sga Expense Q1 2012 · May 31, 2011 $11.55M
Net Income Q1 2012 · May 31, 2012 −$450.78K
Net Income Q1 2012 · May 31, 2011 −$13.39M
Cost Of Revenue Q1 2012 · May 31, 2012 $229
Cost Of Revenue Q1 2012 · May 31, 2011 $52.86K
Revenue Q1 2012 · May 31, 2012 −$1.24K
Revenue Q1 2012 · May 31, 2011 $4.21K